Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-01-03 @ 12:25 PM
Study NCT ID:
NCT03514069
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-08
First Post:
2018-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
Sponsor:
Organization: